These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6681482)

  • 1. Partial plasma protein replacement in therapeutic plasma exchange.
    McLeod BC; Sassetti RJ; Stefoski D; Davis FA
    J Clin Apher; 1983; 1(2):115-8. PubMed ID: 6681482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentastarch as partial replacement fluid for therapeutic plasma exchange: effect on plasma proteins, adverse events during treatment, and serum ionized calcium.
    Goss GA; Weinstein R
    J Clin Apher; 1999; 14(3):114-21. PubMed ID: 10540365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein and colloid osmotic pressure changes with albumin and/or saline replacement during plasma exchange.
    Lasky LC; Finnerty EP; Genis L; Polesky HF
    Transfusion; 1984; 24(3):256-9. PubMed ID: 6729943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Replacement fluids in therapeutic plasma exchange ].
    Nydegger U
    Ther Umsch; 1982 Jul; 39(7):560-4. PubMed ID: 7123510
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of membrane filtration, influence on hemostasis, immunoglobulins and inflammation mediators during daily plasma exchanges.
    Rawer P; Wizemann V; Schoendorf T; Schuetterle G
    Int J Artif Organs; 1983 Jul; 6 Suppl 1():97-101. PubMed ID: 6642746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange. The Canadian Apheresis Group.
    Rock G; Sutton DM; Freedman J; Nair RC
    J Clin Apher; 1997; 12(4):165-9. PubMed ID: 9483177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange.
    McLeod BC
    Best Pract Res Clin Haematol; 2006; 19(1):157-67. PubMed ID: 16377548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience of using human albumin solution 4.5% in 1195 therapeutic plasma exchange procedures.
    Pusey C; Dash C; Garrett M; Gascoigne E; Gesinde M; Gillanders K; Wallington T
    Transfus Med; 2010 Aug; 20(4):244-9. PubMed ID: 20230532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haptoglobin is present in albumin used as a replacement solution for plasma exchange.
    Cid J; Elena M; Diekmann F; Lozano M
    Transfusion; 2013 Apr; 53(4):757-60. PubMed ID: 22803596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of fresh-frozen plasma as a replacement fluid to neutralize ABO antibodies.
    Won DI; Ham JY; Kim CD; Suh JS; Kim BC
    J Clin Apher; 2015 Oct; 30(5):288-96. PubMed ID: 25546477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyethylstarch as replacement in therapeutic plasma exchange.
    Burgstaler EA; Pineda AA
    Prog Clin Biol Res; 1990; 337():395-7. PubMed ID: 1693783
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of hypotensive reactions is increased when using partial saline replacement for therapeutic plasma exchange.
    Irani MS; Toushan M; Zhang L; Simpson PM; Karafin MS
    J Clin Apher; 2019 Oct; 34(5):524-527. PubMed ID: 30888726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice of the replacement fluid during large volume plasma-exchange.
    Nydegger UE
    Ric Clin Lab; 1983; 13(1):103-9. PubMed ID: 6344175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange using dextran 40-electrolyte solution as the sole replacement fluid in malignant paraproteinemia.
    Fujii H
    Transfusion; 1988; 28(1):42-5. PubMed ID: 2448929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the changes in plasma proteins following plasma exchange with albumin or fresh frozen plasma.
    Rock G; McCombie N
    Prog Clin Biol Res; 1990; 337():403-4. PubMed ID: 2353003
    [No Abstract]   [Full Text] [Related]  

  • 16. Salicylate removal during plasma exchange in normal volunteers.
    White RL; Garnett WR; Poynor WJ; Allen JH; Sharp DE
    Clin Pharm; 1984; 3(4):396-402. PubMed ID: 6467875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadsorption and plasma exchange in multiple sclerosis: complement and plasma protein behaviour.
    Palm M; Behm E; Schmitt E; Buddenhagen F; Hitzschke B; Kracht M; Kundt G; Meyer-Rienecker H; Klinkmann H
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):283-96. PubMed ID: 1751678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modification of hemorrheologic and laboratory chemical parameters by infusion therapy and preserved serum and by plasma exchange with human albumin and preserved serum in patients with posterior and intermediate uveitis].
    Jahn M; Brunner R; Borberg H; Kadar J; Kreutzer A; Hossmann V
    Fortschr Ophthalmol; 1988; 85(6):740-3. PubMed ID: 3220395
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic plasma exchange in a single center: Ibni Sina experience.
    Arslan O; Arat M; Tek I; Ayyildiz E; Ilhan O
    Transfus Apher Sci; 2004 Jun; 30(3):181-4. PubMed ID: 15172620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exchange in multiple sclerosis.
    Guarnieri BM; Capparelli R; Fratiglioni L; Inzitari D; Sità D; Amaducci L; Avanzi G; Biani D; Franco C; Lombardo R
    Int J Artif Organs; 1985 Jul; 8(4):215-20. PubMed ID: 3902665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.